Status:
COMPLETED
Comparative Evaluation of smART+ REE Module to an FDA-cleared Device, for REE Calculation in ICU Patients
Lead Sponsor:
ART Medical Ltd.
Conditions:
Comparative Study
REE
Eligibility:
All Genders
22+ years
Brief Summary
A prospective, single-center, comparative evaluation of smART+ REE Module to an FDA-cleared REE Module device, for REE calculation in ICU Patients.
Detailed Description
Mechanically ventilated patients are unable to take food orally and therefore are dependent on enteral nutrition for provision of both energy and protein requirements. The conditions of ICU patients d...
Eligibility Criteria
Inclusion
- Males and females 22 years or older
- Patient has already been admitted to ICU
- Patient expected to be ventilated at least 24 hours after enrollment
- Patients should be stable hemodynamically (no increase/decrease in vasopressors) and respiratory (no change in mechanical ventilation settings) for at least 1 hour prior to initiation of study procedures.
Exclusion
- Women who are pregnant
- Patient requiring chest drainage
Key Trial Info
Start Date :
August 12 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07165080
Start Date
August 12 2025
End Date
October 30 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beilinson Medical Center
Petah Tikva, Hasharon, Israel